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AbstrAct
Introduction: Malignant renal tumours (MRTs) pose significant morbidity and mortality.  In adults, renal cell carcinoma 
(RCC) constitutes about 90% of these tumours whereas in children, the majority are nephroblastomas. Males are 
generally more affected than females. Nuclear grade, tumour stage, size and histopathological subtype are prognostic 
factors. In our environment, patients with MRTs commonly present late.
Methods: Clinical and demographic details of patients who had malignant tumours diagnosed on renal biopsy 
tissue between 2002 and 2013 at the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria, were 
extracted from pathology request forms. Slides were retrieved from the archives and reviewed. The tumours were 
classified according to WHO and ISUP criteria.
Results: Kidney biopsies constituted 0.8% of the biopsy specimens processed within the period; 60% of these were 
malignant lesions. Half (51%) of the patients with MRTs were males and 81% were children (the majority aged 0–4 
years).  Among children, the incidence decreased steadily with age. Seventy-three percent were nephroblastomas, 
exclusively occurring in children. Renal cell carcinoma constituted 19.4%, with papillary carcinoma being the 
commonest subtype, whereas non-Hodgkin’s lymphoma and rhabdomyosarcoma constituted 6% and 1.5%, 
respectively. The mean gross weight of the tumour masses was 1.3 kg and the average duration of symptoms prior 
to presentation was 18.3 months. The majority presented with abdominal masses.
Conclusions: Although the renal biopsy rate is generally low in our environment, we found that the most common 
renal malignancy was nephroblastoma in children. In adults, renal cell carcinoma, mainly of the papillary type, was 
predominant. Most cases present late.
Keywords: Malignancy; nephroblastoma; renal cell carcinoma; Port Harcourt; Nigeria.
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INtrODUctION
Malignant renal tumours (MRTs) are the third-most 
common genitourinary malignancies in adults [1,2], con-
stituting about 3% of all human malignant tumours. They 
are predominantly primary, often arise from the renal 
parenchyma and pelvis, and are commonly of epithelial 
origin. The majority are adenocarcinomas, and referred 
to as renal cell carcinoma (RCC). In adults, RCC con-
stitutes about 90% of MRTs whereas in children the 
majority are nephroblastomas (Wilms’ tumour).
RCC is the 15th-most common cancer worldwide with 
high incidence rates in Europe and North America and 
lower incidence rates among Africans and Asians. The 
risk factors include cigarette smoking, obesity and 
hypertension [2-4]. Increased risk of renal carcinoma is 
associated with high parity among women, especially 
those who gave multiple births at a young age [5]. 
Long exposure to chemicals such as asbestos, lead 
and polycyclic aromatic hydrocarbons also confers 
increased risk [6]. While physical inactivity is associated 
with the risk of renal carcinoma, alcohol consumption 
is said to confer protection [7,8]. Fluid intake from 
beverages including coffee, tea and soda demonstrates 
no association with renal carcinoma [9].
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The rate of gender involvement varies according to 
geographic region but males are generally more often 
affected than females. For example, the incidence among 
males across Europe is more than five times that of females, 
whereas in Nigeria there is more male involvement but 
not with as wide a margin as recorded in European reports 
[10-14]. A few local authors have reported a greater 
prevalence in women [15,16].
Fuhrman nuclear grade, tumour stage, size and histo-
pathological subtype are important prognostic factors in 
RCC [12,17]. Clear cell renal cell carcinoma has a worse 
prognosis when compared with chromophobe or papillary 
subtypes [17]. While early stage, small, and organ confined 
tumours are increasingly diagnosed in developed countries, 
late stage, large and non-organ confined tumours are com-
monly encountered in Nigeria owing to late presenta- 
tion and poor radiodiagnostic infrastructure to evaluate 
patients [12,15].
Although previous reports indicate that MRTs are 
uncommon in Nigeria, there is need for periodic review to 
ascertain the trends and plan appropriately [11,12]. This 
study, which reviews MRTs between 2002 and 2013, is a 
follow-up to the one conducted in our centre between 
1990 and 2001 [11].
MEtHODs 
This was a retrospective study carried out in the Depart-
ment of Anatomical Pathology department of the Uni-
versity of Port Harcourt Teaching Hospital (UPTH), Port 
Harcourt, Nigeria. UPTH is the foremost tertiary health 
institution in the Niger Delta region, with adequate and 
competent urological and paediatric surgery staff. It serves 
a large patient population drawn from the Delta region in 
general and more specifically from Rivers state. The study 
covered the period 2002 to 2013. Information on patients 
whose kidney biopsies were diagnosed as malignant in 
the histopathology laboratory were extracted; this included 
clinical and demographic details from patient request 
forms and the department’s accessioning register. Relevant 
slides were retrieved from archives and reviewed. Where 
necessary, new slides were made from formalin-fixed, 
paraffin-embedded tissue blocks and stained with haema-
toxylin and eosin. The tumours were classified accordance 
to the WHO histological criteria. The data were analysed 
using SPSS version 20.
rEsULts
During the 12-year review period (2002–2013), 112 kidney 
biopsies were received, constituting 0.8% of the 14 564 
specimens processed. Of these, 67 cases (60%) were 
malignant lesions while 45 cases (40%) were non-neoplastic. 
The 67 patients with malignant tumours all underwent 
radical nephrectomies. 
Approximately half of the patients (34, 51%) were males 
(Table 1). Children and adolescents aged between 0–19 
years constituted 54 cases (81%) and adults the remaining 
13 cases (19%) (Table 2). The bulk of childhood malig-
nancies were seen in children under 10 years old (46 cases, 
85% of this group) with those aged 0–4 years contributing 
29 of these cases. Overall, among children the incidence 
decreased steadily with increasing age whereas in adults 
the incidence increased with age, peaking at 50–59 years 
(Table 3). 
The majority of the tumours were nephroblastomas (73%) 
and ages 0–4 carried the greatest burden (54%) (Table 3). 
Renal cell carcinoma constituted only 13 cases while non-
Hodgkin’s lymphoma and rhabdomyosarcoma followed 
with 4 cases (6%) and 1 case (1.5%), respectively. Nephro-
blastoma occurred exclusively in children whereas the 
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table 1.  Overview of the renal malignancies and their 
gender distribution.
Malignant type Male Female Total (%)
1 Nephroblastoma 23 26 49 (73%)
2 Papillary RCC 5 1 6 (9%)
3 Clear cell RCC 2 3 5 (7%)
4 NHL (Burkitt’s) 3 1 4  (6%)
5
Collecting duct 
carcinoma
0 1 1
6 Rhabdomyosarcoma 1 0 1
7 TCC 0 1 1
Total 34 33 67 (100%)
RCC, renal cell carcinoma; NHL, non-Hodgkin’s lymphoma;  
TCC, transitional cell carcinoma.
table 2.  Age distribution of childhood renal malignancies.
Age Nephroblastoma NHL RCC Total (%)
0–4 29 0 0 29 (54)
5–9 13 2 0 15 (28)
10–14 3 2 1 6 (11)
15–19 4 0 0 4 (7)
Total 49 4 1 54 (100)
RCC, renal cell carcinoma; NHL, non-Hodgkin’s lymphoma.
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other malignant lesions were found exclusively in adults. 
In decreasing order, the subtypes of RCC included papillary 
(6 cases), clear cell (5 cases), collecting duct (1 case) and 
transitional cell carcinoma (1 case). 
Among patients with information on the side affected, the 
right kidney was involved 2.5 times more than the left 
(Table 4). The gross weight of the tumour ranged between 
100 g and 5.5 kg with a mean of 1.3 kg and the gross 
dimensions ranged between 10 x 7 x 5 cm and 29 x 23 x 
12 cm. The majority of the RCC cases were of the ISUP 
grade 2 type, whereas only one case each was of grades 
1 and 4.
Among the nephroblastomas, there were no atypical cases 
noted. Most of the patients presented with an abdominal 
mass whereas haematuria was the least frequent pre-
sentation (Table 5). The average duration of symptoms 
prior to presentation was 18.3 months with a range of 
1–2 years.
DIscUssION
Kidney biopsies constituted 0.8% of the 14 564 specimens 
processed in the department within the 12-year period, 
with malignant tumours constituting only 67 cases (0.5%). 
UPTH serves a large patient population from the Delta 
region, and more specifically Rivers state. This suggests a 
relatively low incidence of malignant renal lesions in the 
region, which represents 5 of the 36 states that make up 
Nigeria. These findings are also consistent with previous 
reports that MRTs are uncommon in Nigeria [11,12,14, 
18,19]. The known risk factors are not uncommon in 
Nigeria, especially in the Niger Delta region, where decades 
of poorly regulated oil and gas activities have led to 
pronounced air, water and land pollution [20]. It is there-
fore likely that the reason for the low prevalence is more 
genetic than environmental. This is in line with the observa-
tion by Stiller that the variation in patterns of incidence 
of Wilms’ tumours along ethnic rather than geographical 
lines suggests that genetic disposition is important in its 
aetiology [21].
The issue of under-diagnosis and underreporting may also 
be important. Owing to the poor health infrastructure and 
the use of alternative solutions including spiritual healing 
and traditional medicine, a sizeable (but unknown) pro-
portion of the populace do not present to hospitals. 
It has been reported that the incidence of nephroblastoma 
in Africa is underestimated as some cases are not brought 
to the attention of medical personnel [22]. Furthermore, 
Tijani et al. have suggested that many cases present in an 
advanced, inoperable condition and histopathology is never 
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table 3.  Age distribution of adult renal malignancies.
Age Papillary  carcinoma
Clear cell  
carcinoma
Collecting duct  
carcinoma
Transitional cell 
carcinoma
Rhabdomyo- 
sarcoma Total (%)
20–29 2 - - - - 2 (15)
30–39 1 2 - - - 3 (23)
40–49 - 2 1 - - 3 (23)
50–59 2 1 - 1 1 5 (39)
≥60 - - - - - -
Total 5 5 1 1 1 13 (100)
table 4.  Malignancy types and side of involvement
Lesion Right Left Unknown Total 
Nephroblastoma 17 7 25 29 (54)
Renal cell  
carcinoma
6 1 6 15 (28)
NHL - 1 3 6 (11)
Rhabdomyo- 
sarcoma
- - 1 4 (7)
Total 23 (34%) 9 (13%) 35 (52%) 67 (100%)
table 5.  Frequency of presenting symptoms and signs.
Symptoms and signs Number (%)
Abdominal mass 21 (31)
Persistent haematuria 3 (5)
Intermittent haematuria 3 (5)
Weight loss 15 (22)
Anaemia/weakness 7 (10)
Multiple combined symptoms 18 (27)
Total 67 (100)
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obtained [15]. In contrast, the incidence among Western 
countries has been on the increase partly due to early 
diagnosis brought about by routine medical examinations 
as well as the availability of modern health-care facilities 
with state-of-the-art radiological diagnostic equipment. 
Children and adolescents aged between 0–19 years 
constituted 81% of the cases in our study. This predomi-
nance of MRTs among children is consistent with the report 
of a similar study conducted a decade earlier by Seleye-
Fubara et al. in our institution [11]. Similarly, Mandong, in 
Jos and Isa et al. in Sokoto, observed a predominance of 
MRTs among children with nephroblastoma accounting for 
57% and 48% of MRTs in Jos and Sokoto, respectively 
[10,14]. The marked preponderance of MRT among 
children is a cause for concern and sharply contrasts with 
findings in Western countries and in Pakistan, where more 
adults are involved [14]. There are no clear reasons for this 
difference but it is possible that environmental influences, 
such as environmental pollution, and genetic factors are 
involved.
The gender ratio in this study was balanced as only 34 of 
the 67 cases were males. Results from previous Nigerian 
studies have been inconsistent, with some researchers 
observing more males and others more females [10–16]. 
The previous study conducted in our centre a decade 
earlier indicated only a marginal predominance of males, 
with a male: female ratio of 1.6:1, comparable to the 1.2:1 
reported by Orlu-Eddo et al. in Benin [11,19].
Of the childhood renal malignancies in this study, ages 0–4 
years were most affected, constituting 53% of childhood 
cases. Nephroblastoma, which is the most common child-
hood tumour and relatively uncommon in adults, was by far 
the most common malignant renal lesion in this study. This 
is consistent with the literature. According to cancer 
research in the UK, around 85 cases of kidney cancer are 
diagnosed each year in children (0–14-year-olds), with 
around three-quarters of these occurring in those under 
the age of five [14,28]. Patients under 2 years of age have 
significantly fewer metastases and a better 5-year survival 
rate than those older than 2 years.
Our patients do not enjoy such a good prognosis despite 
their young age owing to factors such as late presentation, 
poor care and suboptimal management related to 
inadequate treatment infrastructure. The gross weight of 
the tumours ranged between 100 g and 5.5 kg with a mean 
of 1.3 kg and the gross dimensions ranged between 10 x 7 
x 5 cm and 29 x 23 x 12 cm. Larger tumours have a 
worse prognosis and indicate late presentation. Reports 
from similar studies corroborate this finding that late stage, 
large and non-organ confined tumours are commonly 
encountered among Nigerian patients [12,14,16].12, 14, 16 
In contrast, the average tumour size reported in most 
developed societies ranges from 5–8 cm (average 5.4 cm) 
and less than 0.5 kg in weight [25]. This speaks to the poor 
societal health culture complicated by poor infrastructure 
in the health sector, lack of social security and pervading 
poverty among the populace. 
None of the nephroblastoma cases met the criteria for 
qualification as an atypical case. The criteria include marked 
nuclei enlargement of the blastemal, epithelial, or stromal 
cell lines, obvious hyperchromasia of the enlarged nuclei 
and multipolar mitotic figures [26].
RCC predominated among the adults with a 2:1 male:female 
ratio. This is consistent with the literature as a whole but 
contrary to the findings of Tijani et al. in Lagos and Isah et 
al. in Sokoto [14,15]. The peak age range was 50–59 years. 
This is consistent with earlier reports on RCC in the eastern 
and western parts of Nigeria [12,18]. It suggests that the 
peak incidence of MRT in Nigeria occurs earlier than the 
50–70 years reported for Whites in the Unites States [27].
At the consensus conference of the International Society 
of Urological Pathology (ISUP) in 2012, a novel grading 
system (the ISUP grading system) was adopted, replacing 
the Fuhrman grading system. ISUP grade 1 tumours are 
defined as having inconspicuous, or absent, nucleoli at 
400x magnification; for ISUP grade 2 tumours, nucleoli 
should be distinctly visible at 400x, but inconspicuous or 
invisible at 100x magnification; and for ISUP grade 3 
tumours, nucleoli should be distinctly visible at 100x 
magnification. ISUP grade 4 tumours include those with 
rhabdoid or sarcomatoid differentiation or containing giant 
cells or showing extreme nuclear pleomorphism with 
clumping of chromatin [28]. The majority of our RCC cases 
were of the ISUP grade 2 with only one case each of grades 
1 and 4.
Abdominal mass, weight loss and haematuria were the 
most common presenting features. This agrees with the 
classic triad of loin pain, abdominal swelling and haematuria, 
which commonly denotes late-presenting lesions. Among 
patients with known side of involvement, the right kidney 
was involved 2.5 times more than the left. In contrast, 
Badmus et al. observed more cases on the left side 
(55%) [12]. We are not aware of any clinical implications 
of the side of involvement. 
cONcLUsIONs
In our study, we found that the most common renal 
malignancy was nephroblastoma in children. In adults, renal 
cell carcinoma, mainly of the papillary type, predominated. 
In most cases, patients present late.
Malignant renal tumours in Port Harcourt, Nigeria
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